Metabolism of Cl36-Dichloromethotrexate by Transplantable Liver Tumors

R. Adamson,T. L. Loo,H. Morris
DOI: https://doi.org/10.3181/00379727-111-27856
1962-12-01
Abstract:Summary Several types of transplantable hepatomas were assayed for their ability to metabolize Cl36-DCM in vitro. The Novikoff tumor lacked the ability to metabolize DCM. The tumor 3683 had a slight amount of enzyme activity. Other tumors assayed, i.e., 5123, 7800, 5123 TC and Reuber hepatomas had activity similar to normal liver. Possible therapeutic implications of these findings were discussed.
What problem does this paper attempt to address?